{
    "title": "114_s586",
    "content": "The Act is titled the \"National Diabetes Clinical Care Commission Act\" and includes findings related to diabetes care. Congress finds that nearly 29 million Americans have diabetes and 86 million have pre-diabetes, with an increase since 2011. Diabetes affects 9.3% of all Americans and 12.3% of adults aged 20 and older, with higher rates among racial and ethnic minorities. Diabetes is prevalent among different ethnic groups, with 12.3% of adults affected in the US. It is the seventh leading cause of death and is associated with various complications such as heart disease, stroke, kidney failure, and amputations. Adults with diabetes have a higher risk of heart disease and stroke, with death rates nearly double that of those without the disease. Diabetes is a significant health concern, leading to kidney failure, nerve disorders, blindness, and lower limb amputations. The total national costs associated with diabetes exceeded $245 billion in 2012, with one in three Medicare dollars spent on people with diabetes. One in three Medicare dollars is currently spent on people with diabetes, and the Centers for Disease Control and Prevention projects that 1 in 3 American adults could have diabetes by 2050. There are 35 Federal departments, agencies, and offices involved in Federal diabetes activities. The National Diabetes Clinical Care Commission is established under the Public Health Service Act to address the increasing prevalence of diabetes in the United States. The National Diabetes Clinical Care Commission is established within the Department of Health and Human Services to evaluate and recommend solutions for better coordination of programs related to clinical care for people with pre-diabetes, diabetes, and related chronic conditions. The Commission is composed of voting members from various Federal agencies and departments. The National Diabetes Clinical Care Commission evaluates and recommends solutions for better coordination of programs related to clinical care for people with pre-diabetes, diabetes, and related chronic conditions. Federal agencies and departments involved include Centers for Medicare and Medicaid Services, Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, Indian Health Service, Department of Veterans Affairs, National Institutes of Health, Food and Drug Administration, and Health Resources and Services. The National Diabetes Clinical Care Commission includes voting members appointed by various agencies and organizations impacting clinical care for individuals with pre-diabetes and diabetes. Additional voting members are appointed by the Comptroller General of the United States in consultation with medical societies and patient advocate organizations with expertise in diabetes care. The National Diabetes Clinical Care Commission includes voting members from various medical specialties and patient advocate organizations. The voting members select a chairperson from the commission members. The National Diabetes Clinical Care Commission shall meet 2-4 times a year, with members serving a 3-year term. The Commission's duties include evaluating programs for diabetes screening benefits and preventive health measures to reduce diabetes-related complications. The National Diabetes Clinical Care Commission will assess current activities and gaps in Federal efforts to support clinicians in providing integrated care for individuals with pre-diabetes, diabetes, and related complications. Recommendations will be made for coordinating federally funded clinical practice support tools and implementing new treatments and technologies. The National Diabetes Clinical Care Commission will evaluate existing programs, recommend new programs if needed, suggest clinical pathways for new technologies and treatments, expand education and awareness for healthcare professionals regarding diabetes management. The National Diabetes Clinical Care Commission will provide guidance on clinical practices for diabetes prevention and related complications, recommend outreach methods for educational resources, and include activities related to public health and nutrition as deemed appropriate. An operating plan for carrying out these activities will be submitted to the Secretary and Congress within 90 days of the Commission's first meeting. The National Diabetes Clinical Care Commission will submit an operating plan to Congress detailing specific activities, members involved, budget, and evaluation for carrying out its duties within 90 days of its first meeting. The National Diabetes Clinical Care Commission will periodically update its operating plan and submit updates to the Secretary and Congress. Within 3 years of its first meeting, the Commission will submit a final report with findings and recommendations to the Secretary and Congress. The Secretary will review the evaluation to determine the continuation of the Commission. Appropriations are authorized for fiscal years 2016, 2017, and 2018 to carry out this section."
}